Predicting the effects of supplemental EPA and DHA on the omega-3 index
Open accessThe DOI matches its Crossref record; 51 of the 54 references it cites were found in a registry or an index.
Abstract
Background Supplemental long-chain omega-3 (n-3) fatty acids (EPA and DHA) raise erythrocyte EPA + DHA [omega-3 index (O3I)] concentrations, but the magnitude or variability of this effect is unclear.Objective The purpose of this study was to model the effects of supplemental EPA + DHA on the O3I.Methods Deidentified data from 1422 individuals from 14 published n-3 intervention trials were included. Variables considered included dose, baseline O3I, sex, age, weight, height, chemical form [ethyl ester (EE) compared with triglyceride (TG)], and duration of treatment. The O3I was measured by the same method in all included studies. Variables were selected by stepwise regression using the Bayesian information criterion.Results Individuals supplemented with EPA + DHA (n = 846) took a mean ± SD of 1983 ± 1297 mg/d, and the placebo controls (n = 576) took none. The mean duration of supplementation was 13.6 ± 6.0 wk. The O3I increased from 4.9% ± 1.7% to 8.1% ± 2.7% in the supplemented individuals ( P < 0.0001). The final model included dose, baseline O3I, and chemical formulation type (EE or TG), and these explained 62% of the variance in response (P < 0.0001). The model predicted that the final O3I (and 95% CI) for a population like this, with a baseline concentration of 4.9%, given 850 mg/d of EPA + DHA EE would be ∼6.5% (95% CI: 6.3%, 6.7%). Gram for gram, TG-based supplements increased the O3I by about 1 percentage point more than EE products.Conclusions Of the factors tested, only baseline O3I, dose, and chemical formulation were significant predictors of O3I response to supplementation. The model developed here can be used by researchers to help estimate the O3I response to a given EPA + DHA dose and chemical form.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it has been shown to produce upper quintile levels of the omega-3 index (O3I) [i.e., erythrocyte EPA+DHA, a validated biomarker of omega-3 intake17, 18]”
From Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals (2026) · cites this paper as [18]
In the citing paper
“Omega-3 dose was categorized as ≤1500 mg/day or >1500 mg/day to distinguish intakes achievable through diet or dietary supplements from those requiring pharmacological formulations.”
From Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals (2026) · cites this paper as [18]
In the citing paper
“For typical Americans, achieving this would require an intake of approximately 1000 mg/d of DHA+EPA18.”
From Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals (2026) · cites this paper as [18]
In the citing paper
“This was later demonstrated by an inverse correlation between the O3I and disease activity [90].”
From Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health (2022) · cites this paper as [90]
Citations
Cites
Bayesian model selection in social research
Raftery, A. E. (1995) · Sociological Methodology · doi:10.2307/271063 · Cited by 6,823
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
The Omega-3 Index: A new risk factor for death from coronary heart disease?
Harris, W. S., & von Schacky, C. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.02.030 · Cited by 1,111
Self-citationMarine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811403 · Cited by 979
Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
The ASCEND Study Collaborative Group (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804989 · Cited by 698 · cited 1×
“role for n–3 fatty acids (FAs) in CVD risk reduction (2), but in 3 major randomized trials reported in late 2018, n–3 FA treatment significantly reduced risk for vascular death (3), myocardial infarction (4), and major adverse cardiovascular events (5).”
BackgroundKatan, M. B., Deslypere, J. P., van Birgelen, A. P., Penders, M., & Zegwaard, M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37132-7 · Cited by 638
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 630
Siscovick, D. S., Barringer, T. A., Fretts, A. M., Wu, J. H. Y., Lichtenstein, A. H., Costello, R. B., Kris-Etherton, P. M., Jacobson, T. A., Engler, M. B., Alger, H. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000482 · Cited by 629
Self-citationRimm, E. B., Appel, L. J., Chiuve, S. E., Djoussé, L., Engler, M. B., Kris-Etherton, P. M., Mozaffarian, D., Siscovick, D. S., Lichtenstein, A. H., & On behalf of the American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology (2018) · Circulation · doi:10.1161/cir.0000000000000574 · Cited by 500
Self-citationPosition of the Academy of Nutrition and Dietetics: Dietary Fatty Acids for Healthy Adults
Vannice, G., & Rasmussen, H. (2014) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.11.001 · Cited by 409
Research works printed but not linked: 1
- Luley, 1990, Bioavailability of omega-3 fatty acids: ethyl ester preparations are as suitable as triglyceride preparations, Akt Ernaehr Med., 15, 123
Cited by
Blood omega-3 fatty acids and death from COVID-19: A pilot study
Asher, A., Tintle, N. L., Myers, M., Lockshon, L., Bacareza, H., & Harris, W. S. (2021) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2021.102250 · Cited by 118
Self-citationOmega-3 world map: 2024 update
Schuchardt, J. P., Beinhorn, P., Hu, X. F., Chan, H. M., Roke, K., Bernasconi, A. A., Hahn, A., Sala‐Vila, A., Stark, K. D., & Harris, W. S. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101286 · Cited by 117
Self-citationThe influence of dietary and supplemental omega-3 fatty acids on the omega-3 index: A scoping review
Dempsey, M., Rockwell, M. S., & Wentz, L. M. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1072653 · Cited by 86
Omega-3 Fatty Acids in Pregnancy—The Case for a Target Omega-3 Index
von Schacky, C. (2020) · Nutrients · doi:10.3390/nu12040898 · Cited by 84
Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health
Rodriguez, D., Lavie, C. J., Elagizi, A., & Milani, R. V. (2022) · Nutrients · doi:10.3390/nu14235146 · Cited by 81
“This was later demonstrated by an inverse correlation between the O3I and disease activity [90].”
Background
Metadata
- Authors
- Walker, R. E., Jackson, K. H., Tintle, N. L., Shearer, G. C., Bernasconi, A., Masson, S., Latini, R., Heydari, B., Kwong, R. Y., Flock, M., Kris-Etherton, P. M., Hedengran, A., Carney, R. M., Skulas-Ray, A., Gidding, S. S., Dewell, A., Gardner, C. D., Grenon, S. M., Sarter, B., Newman, J. W., Pedersen, T. L., Larson, M. K., & Harris, W. S.
- Affiliations
- Pennsylvania State University (US)
- Dordt University (US)
- Mario Negri Institute for Pharmacological Research (IT)
- University of Calgary (CA)
- Brigham and Women's Hospital (US)
- University of Pittsburgh (US)
- Glostrup Hospital (DK)
- Washington University in St. Louis (US)
- Stanford University (US)
- University of California, San Francisco (US)
- Bastyr University (US)
- Agricultural Research Service (US)
- University of California, Davis (US)
- Augustana University (US)
- University of South Dakota (US)
- ORCID
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 110
- Issue
- 4
- Pages
- 1034-1040
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2967286362
- Cited by
- 93
- References
- 54
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 16 · 2023: 9 · 2022: 17 · 2021: 13 · 2020: 15 · 2019: 3
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1226 d)
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Dordt Digital Collections (Dordt College) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- OmegaQuant Analytics, LLC
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- omega-3 index, EPA, docosahexaenoic acid, omega-3 supplementation, erythrocyte fatty acids, dose-response relationship, prediction model
- MeSH terms
- Bayes Theorem, Docosahexaenoic Acids, Erythrocytes, Female, Humans, Male, Middle Aged, Models, Biological, Eicosapentaenoic Acid, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predicting the effects of supplemental EPA and DHA on the omega-3 index. https://app.cochat.ai/papers/10.1093/ajcn/nqz161
- The paper
- Walker, R. E., Jackson, K. H., Tintle, N. L., Shearer, G. C., Bernasconi, A., Masson, S., Latini, R., Heydari, B., Kwong, R. Y., Flock, M., Kris-Etherton, P. M., Hedengran, A., Carney, R. M., Skulas-Ray, A., Gidding, S. S., Dewell, A., Gardner, C. D., Grenon, S. M., Sarter, B., . . . Harris, W. S. (2019). Predicting the effects of supplemental EPA and DHA on the omega-3 index. The American Journal of Clinical Nutrition. https://doi.org/10.1093/ajcn/nqz161
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.